CCLG Rhabdomyosarcoma (RMS) Project Grant
Closing Date: 07/02/2024
Three-year project grant to support research to improve understanding of paediatric rhabdomyosarcoma (RMS) and help improve the outlook for children diagnosed with RMS, focusing on high risk, refractory and relapsed RMS.
The Children’s Cancer and Leukaemia Group (CCLG) is a leading support charity for children and young people with cancer and the professional association for medical professionals involved in the treatment and care of children with cancer in the UK and Ireland. CCLG is a member of the Association of Medical Research Charities (AMRC) and provides a range of funding from its own resources, partner charities and named funds to support research in identified areas of need.
The CCLG Rhabdomyosarcoma Project Grant aims to support research to address a key question to improve understanding of paediatric rhabdomyosarcoma (RMS) and help improve the outlook for children diagnosed with higher-risk forms of RMS, including refractory and relapsed RMS.
Grants may support stand-alone projects, research that is part of a wider project or trial, or research that is likely to lead to a further, larger grant application to a major research funder. CCLG is particularly interested in projects that will lead to improved treatments, with reduced side effects, and research into novel therapies – including those that look to apply promising developments from other cancer types.
Projects must align with the CCLG research strategy, which requires that funded research projects will:
- Broaden and deepen knowledge of childhood cancer.
- Assist in transferring research progress from the laboratory to clinical practice.
- Improve treatment or patient care in the short, medium or long term.
- Investigate and aim to reduce the long-term effects of treatment.
Proposed projects should also address one or more of the Top 10 Research Priorities for Childhood Cancer published by the Children’s Cancer Priority Setting Partnership.